--(BUSINESS WIRE)--The mission of ExThera Medical is to develop and introduce life-saving medical devices that quickly and safely remove infectious agents from human blood. These include bacteria and their toxins, viruses, virulence factors and pro-inflammatory cell mediators that lead to a systemic inflammatory response. ExThera’s initial focus is the treatment of bacteremia for the prevention of complicated metastatic infections and sepsis, a top-10 cause of death in the United States, and a significant healthcare problem across the globe.
Sepsis — and in its most severe stage, septic shock — is an extremely dangerous, and frequently deadly affliction that results from bacterial, viral, and/or fungal infections. Pathogen concentration in blood and duration of bacteremia have been shown to be strongly correlated with high patient morbidity and mortality, and increased risk of metastatic infection, such as endocarditis and osteomyelitis.
Company: |
ExThera Medical | |
Headquarters Address: |
813 Heinz Ave | |
Berkeley, CA 94710 | ||
Main Telephone: |
510-809-2500 | |
Website: |
||
Type of Organization: |
Private | |
PR | ||
Industry: |
Biotechnology | |
Key Executives: |
President: Robert Ward, PhD |
|
Executive Vice President: George Pitarra, Jr. |
||
Public Relations |
||
Contact: |
Ronald Trahan | |
Phone: |
5083594005 | |
Email: |